IMTX
IMTX
NASDAQ · Biotechnology

Immatics Nv

$9.78
+0.58 (+6.30%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +689.9% upside
Low Target $52.47
Average Target $77.25
High Target $103.74
Current Price $9.78
Current
$9.78
Target
$77.25
$52.47 $77.25 avg $103.74
Scenario Analysis
Bear Case
$52.47
436.5%
Low target
Base Case
$77.25
+689.9%
Avg target
Bull Case
$103.74
+960.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$12.41
-21.2% from high
52-Week Low
$3.30
+196.4% from low
Target vs 52W High
$77.25
+522.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%